References
- Berger B. J., Hall J. E., Tidwell R. R. The distribution of multiple doses of pentamidine in rats. Pharmacology and Toxicology 1990; 66: 234–236
- Berger B. J., Reddy V. V., Le S. T., Lombardy R. J., Hall J. E., Tidwell R. R. Hydroxylation of pentamidine by rat liver microsomes. Journal of Pharmacology and Experimental Therapeutics 1991; 256: 883–889
- Colthorpe P., Farr S. J., Taylor G., Smith I., Wyatt D. The pharmacokinetics of pulmonary delivered insulin. A comparison of intratracheal and aerosol administration to the rabbit. Pharmaceutical Research 1992; 9: 764–768
- Conte J. E., Golden J. A. Concentrations of aerosolidised pentamidine in bronchoalveolar lavage, systemic absorption and excretion. Antimicrobial Agents and Chemotherapy 1988; 32: 1490–1493
- Debs R., Blumenfeld W., Brunette E. N., Struabinger R. M., Montgomery A. B., Lin E., Agabain N., Papahadjopoulos D. Successful treatment with aerosolised pentmadine of Pneumocystis carinii pneumonia in rats. Antimicrobial Agents and Chemotherapy 1987; 31: 37–41
- Domin B. A., Devereux R., Philpot R. M. The cytochrome P-450 monooxygenase system of the rabbit lung: Enzyme components, activities, and induction in the non-ciliated bronchiolar epithelial (Clara) cell, alveolar type II cell, and alveolar macrophage. Molecular Pharmacology 1986; 30: 296–303
- Girard P., Brun-Pascaud M., Farinotti R., Tamisier L., Kernbaum S. Pentamidine aerosol in prophylaxis and treatment of murine Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy 1987; 31: 978–981
- Goa K. L., Campoli-Richards D. M. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Drugs 1987; 33: 242–258
- Jones H. E., Blundell G. K., Wyatt I., John R. A., Farr S. J., Richards R. J. The accumulation of pentamidine into rat lung slides and its interaction with putrescine. Biochemical Pharmacology 1992; 43: 431–437
- Monk J. P., Benfield P. Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia. Drugs 1990; 39: 741–756
- Richards R., Dickson C. R., Renwick A. G., Lewis R. A., Holgate S. T. Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique. The Journal of Pharmacology and Experimental Therapeutics 1987b; 241: 1028–1032
- Richards R. J., Davies N., Atkins J., Oreffo V. I. C. Isolation, biochemical characterisation and culture of lung type II cells of the rat. Lung 1987a; 165: 143–158
- Richards R. J., Tetley T. D., Hunt J. A. Biological reactivity of calcium silicate composites. II. In-vivo studies. Environmental Research 1981; 26: 243–257
- Force Service Task. US Public Health, Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV. Journal of the American Medical Association 1992; 267: 2294–2299
- Waldman R. H., Pearce D. E., Martin R. A. Pentamidine isothionate levels in lungs, livers, and kidneys of rats after aerosol or intramuscular administration. American Review of Respiratory Disease 1973; 108: 1004–1006
- Wharton J. M., Coleman D. L., Wofsey C. B., Luce J. M., Blumenfeld W., Hadley W. K., Ingram-Drake L., Volberding P. A., Hopewelll P. C. Trimethoprim-sufamethoxazole or pentamidine for Pneumocystis carinii pheumonia in acquired immunodeficiency syndrome. A prospective randomised trial. Annals of Internal Medicine 1986; 105: 37–44
- Wingen F., Bragas B. Autoradiographic examination of the organ distribution of 14C labelled pentamidine in rats after intravenous and inhaled administration. Drug Research 1991; 41: 937–945